latest news releases from the newsroom
Dr. Peter Ringrose joins Astex Board
CAMBRIDGE, United Kingdom, Feb. 01, 2005 (PRIMEZONE) -- * Astex Technology, the fragment-based drug discovery and development company, today announced the appointment of Dr Peter Ringrose to its Board * Dr Ringrose brings more than 30 years of pharmaceutical industry experience, with senior positions previously held at Bristol-Myers Squibb, Pfizer, Sandoz and Roche. * He will strengthen Astex's board as the Company prepares to take the first of its oncology drugs into the clinic during 2005
Agreement reached between Skandia Insurance Company Ltd and Lars Ramqvist
STOCKHOLM, Sweden, Feb. 1, 2005 (PRIMEZONE) -- Skandia Insurance Company Ltd ("Skandia") and its former chairman, Lars Ramqvist, reached an agreement on 31 January 2005. Under the terms of the agreement, Ramqvist has offered to repay all fees he received as chairman of Skandia's board, its audit committee and its nominating committee during the years 2000 and 2001, totalling SEK 2,216,667.
EQT and ISS in Joint Venture in Health Care and Care of the Elderly
STOCKHOLM, Sweden, Feb. 1, 2005 (PRIMEZONE) -- ISS and the EQT III Fund ("EQT") have decided today to form a new joint venture company that will be jointly owned by ISS and EQT, and in which the new management team has been offered the opportunity to acquire shares. The new company consists of ISS Health Care AB and CarePartner AB, two companies operating in health care, rehabilitation and treatment of substance abuse, psychiatry and care of the elderly and disabled. The new company will have sales of about SEK 1.7 billion.
Skandia: Directors' Liability
STOCKHOLM, Sweden, Feb. 1, 2005 (PRIMEZONE) -- At Skandia's Annual General Meeting on 15 April 2004, the Board of Directors and President were not granted discharge from liability for the period 1 January -- 15 April 2003. As a result of the AGM's decision, Skandia's board commissioned attorneys Peter Danowsky and Otto Rydbeck to each give their individual recommendations to the Board regarding which legal measures that the decision to not grant discharge from liability could give rise to. The Board also assigned Danowsky and Rydbeck to determine if there is reason with respect to previous periods to demand liability for damages from the former board, CEO and auditors. The limitation period for the ability to take legal action for such liability has already expired for 2000 and earlier.
Skandia -- Information on International Financial Reporting Standards (IFRS)
STOCKHOLM, Sweden, Feb. 1, 2005 (PRIMEZONE) -- Today, 1 February 2005, Skandia will hold a briefing for institutional investors and financial analysts to provide an overview of how Skandia's financial reporting will be impacted by the introduction of International Financial Reporting Standards (IFRS). The presentation will provide background to the development of the IFRS requirements, the changes in accounting principles for Skandia and our current understanding of the impact on formats, opening equity as per 1 January 2004 and net income for the first half of 2004.
President of Skanska USA Building to leave the company
STOCKHOLM, Sweden, Feb. 1, 2005 (PRIMEZONE) -- Mike Healy, President of the Skanska USA Building unit will leave the company immediately. Until a permanent replacement is named, Johan Karlstrom, Executive Vice President Skanska AB, will head the business unit as acting president.
Tele2 Acquires Tiscali's Danish Operations
NEW YORK and STOCKHOLM, Sweden, Feb. 1, 2005 (PRIMEZONE) -- Tele2 AB ("Tele2") (Nasdaq:TLTOA) (Nasdaq:TLTOB) (Stockholmsborsen: TEL2A and TEL2B), the leading alternative pan-European telecommunications company, today announced that it has acquired Tiscali's Danish operations, Tiscali Denmark A/S, for MEUR 20.7 on a debt-free basis.
Vestin Group, Inc.
Vestin Group Files 8-K Relating to Anticipated Move From Nasdaq SmallCap to OTC Bulletin Board
LAS VEGAS, Jan. 31, 2005 (PRIMEZONE) -- Vestin Group Inc. (Nasdaq:VSTN) today announced that it has received notification from Nasdaq stating that the company's common shares will be delisted from The Nasdaq SmallCap Market effective at the opening of business on February 3, 2005. Nasdaq said the deslisting is based upon its staff's determination that Vestin does not meet the minimum publicly held shares required for continued inclusion in the SmallCap Market.